PCM
ELOS

Penserra Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Penserra Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,035
Closed -$74K – 614
2017
Q1 		$74K Buy
7,035
+3,015
+75% +$29.2K 0.01% 312
2016
Q4 		$33K Sell
4,020
-732
-15% -$5.74K ﹤0.01% 431
2016
Q3 		$34K Buy
4,752
+1,188
+33% +$8.26K ﹤0.01% 398
2016
Q2 		$27K Buy
3,564
+62
+2% +$442 ﹤0.01% 449
2016
Q1 		$25 Buy
3,502
+1,167
+50% +$8.36K ﹤0.01% 429
2015
Q4 		$18K Buy
+2,335
New +$17.8K ﹤0.01% 432

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Penserra Capital Management's ELOS Position: Q2 2017 in Review

Penserra Capital Management sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 7,035 shares — an estimated $74K sold.

Penserra Capital Management first reported a position in ELOS in Q4 2015 and held it in 6 quarters. The position peaked at $74K in Q1 2017. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Penserra Capital Management reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Penserra Capital Management sold 7,035 Syneron Medical Ltd shares in Q2 2017, an estimated $74K.
  • Penserra Capital Management first reported a position in Syneron Medical Ltd in Q4 2015 and held it in 6 quarters.
  • Penserra Capital Management's Syneron Medical Ltd position peaked at $74K in Q1 2017.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Penserra Capital Management's 13F filing for Q2 2017, filed 7 Aug 2017.